In Vitro 3D Spheroid Culture System Displays Sustained T Cell-dependent CLL Proliferation and Survival
暂无分享,去创建一个
A. Kater | P. Moerland | E. Eldering | Danial Lashgari | M. Haselager | Dennis M. de Rooij | E. Perelaer | Bianca F. van Driel | R. Loos
[1] Š. Pospíšilová,et al. RGDS-Modified Superporous Poly(2-Hydroxyethyl Methacrylate)-Based Scaffolds as 3D In Vitro Leukemia Model , 2021, International journal of molecular sciences.
[2] Christopher I. Jones,et al. TLR9 expression in Chronic Lymphocytic Leukemia identifies a pro-migratory subpopulation and novel therapeutic target. , 2021, Blood.
[3] A. Kater,et al. Proliferative Signals in Chronic Lymphocytic Leukemia; What Are We Missing? , 2020, Frontiers in Oncology.
[4] F. Sbrana,et al. Three-dimensional co-culture model of chronic lymphocytic leukemia bone marrow microenvironment predicts patient-specific response to mobilizing agents , 2020, Haematologica.
[5] S. Fernandes,et al. Changes in Bcl-2 members in response to ibrutinib or venetoclax uncover functional hierarchy in determining resistance to venetoclax in CLL. , 2020, Blood.
[6] C. Connine,et al. inhibition , 2020, Catalysis from A to Z.
[7] Catherine J. Wu,et al. Clonal dynamics in chronic lymphocytic leukemia. , 2019, Blood advances.
[8] R. de Boer,et al. Distinct immune composition in lymph node and peripheral blood of CLL patients is reshaped during venetoclax treatment. , 2019, Blood advances.
[9] C. Ziegler,et al. Constitutive Activation of the B Cell Receptor Underlies Dysfunctional Signaling in Chronic Lymphocytic Leukemia , 2019, Cell reports.
[10] L. Miguet,et al. BCR-associated factors driving chronic lymphocytic leukemia cells proliferation ex vivo , 2019, Scientific Reports.
[11] L. Staudt,et al. TLR Signaling Is Activated in Lymph Node-Resident CLL Cells and Is Only Partially Inhibited by Ibrutinib. , 2018, Cancer research.
[12] Xiao-Jie Yan,et al. Mechanistic Insights into CpG DNA and IL-15 Synergy in Promoting B Cell Chronic Lymphocytic Leukemia Clonal Expansion , 2018, The Journal of Immunology.
[13] W. Luyten,et al. Three‐dimensional cell culture models for anticancer drug screening: Worth the effort? , 2018, Journal of cellular physiology.
[14] A. Kater,et al. Chronic lymphocytic leukemia cells are active participants in microenvironmental cross-talk , 2017, Haematologica.
[15] A. Kater,et al. Targeting antigen-independent proliferation in chronic lymphocytic leukemia through differential kinase inhibition , 2017, Leukemia.
[16] Sonali M. Smith,et al. Heightened BTK-dependent cell proliferation in unmutated chronic lymphocytic leukemia confers increased sensitivity to ibrutinib , 2015, Oncotarget.
[17] U. Klein,et al. Mouse models in the study of chronic lymphocytic leukemia pathogenesis and therapy. , 2014, Blood.
[18] N. Chiorazzi,et al. B cell receptor signaling in chronic lymphocytic leukemia. , 2013, Trends in immunology.
[19] E. Remmerswaal,et al. IL-21 and CD40L signals from autologous T cells can induce antigen-independent proliferation of CLL cells. , 2013, Blood.
[20] A. McKenna,et al. Evolution and Impact of Subclonal Mutations in Chronic Lymphocytic Leukemia , 2012, Cell.
[21] M. Minden,et al. Chronic lymphocytic leukaemia is driven by antigen-independent cell-autonomous signalling , 2012, Nature.
[22] C. Geest,et al. The clinically active BTK inhibitor PCI-32765 targets B-cell receptor- and chemokine-controlled adhesion and migration in chronic lymphocytic leukemia. , 2012, Blood.
[23] Jeffrey A Jones,et al. Bruton tyrosine kinase represents a promising therapeutic target for treatment of chronic lymphocytic leukemia and is effectively targeted by PCI-32765. , 2011, Blood.
[24] C. Doglioni,et al. Chronic lymphocytic leukemia: the pathologist's view of lymph node microenvironment. , 2011, Seminars in diagnostic pathology.
[25] T. Kipps,et al. Laser microdissection for the assessment of the clonal relationship between chronic lymphocytic leukemia/small lymphocytic lymphoma and proliferating B cells within lymph node pseudofollicles , 2011, Leukemia.
[26] Richard Sherry,et al. The lymph node microenvironment promotes B-cell receptor signaling, NF-kappaB activation, and tumor proliferation in chronic lymphocytic leukemia. , 2011, Blood.
[27] A. Kater,et al. Dichotomy in NF-κB signaling and chemoresistance in immunoglobulin variable heavy-chain-mutated versus unmutated CLL cells upon CD40/TLR9 triggering , 2010, Oncogene.
[28] C. Peschel,et al. Antiapoptotic effect of interleukin-2 (IL-2) in B-CLL cells with low and high affinity IL-2 receptors , 2010, Annals of Hematology.
[29] M. Piris,et al. Proliferation centers in chronic lymphocytic leukemia: the niche where NF-κB activation takes place , 2010, Leukemia.
[30] Nienke Vrisekoop,et al. In vivo dynamics of stable chronic lymphocytic leukemia inversely correlate with somatic hypermutation levels and suggest no major leukemic turnover in bone marrow. , 2008, Cancer research.
[31] A. Kater,et al. c-Abl kinase inhibitors overcome CD40-mediated drug resistance in CLL: implications for therapeutic targeting of chemoresistant niches. , 2008, Blood.
[32] A. Rosenwald,et al. High-level expression of the T-cell chemokines CCL3 and CCL4 by chronic lymphocytic leukemia B cells in nurselike cell cocultures and after BCR stimulation. , 2007, Blood.
[33] Annelieke Jaspers,et al. Differential Noxa/Mcl-1 balance in peripheral versus lymph node chronic lymphocytic leukemia cells correlates with survival capacity. , 2007, Blood.
[34] M. Gobbi,et al. Interleukin-21 receptor (IL-21R) is up-regulated by CD40 triggering and mediates proapoptotic signals in chronic lymphocytic leukemia B cells. , 2006, Blood.
[35] T. Kipps,et al. Protection of CLL B cells by a follicular dendritic cell line is dependent on induction of Mcl-1. , 2002, Blood.
[36] F. Sallusto,et al. Chronic lymphocytic leukemia B cells are endowed with the capacity to attract CD4+, CD40L+ T cells by producing CCL22 , 2002, European journal of immunology.
[37] C. Peschel,et al. Immunostimulatory CpG-oligonucleotides cause proliferation, cytokine production, and an immunogenic phenotype in chronic lymphocytic leukemia B cells. , 2000, Blood.
[38] P. Griebel,et al. CD40 signaling induces B cell responsiveness to multiple members of the gamma chain-common cytokine family. , 1999, International immunology.
[39] Ondřej Chum,et al. CENTER FOR , 2001 .